Brief: Motus GI Receives FDA Clearance To Market The Pure-Vu EVS System
14/02/2022 12:14
Feb 14 (Reuters) - Motus GI Holdings Inc MOTS.O :
* MOTUS GI RECEIVES FDA CLEARANCE TO MARKET THE PURE-VU® EVS
SYSTEM
* MOTUS GI HOLDINGS INC - PURE-VU EVS COMMERCIALIZATION IN
US
MARKET EXPECTED TO COMMENCE IMMEDIATELY
Source text for Eikon: ID:nGNX8LjC1B
Further company coverage: MOTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Motus GI Holdings
See all newsBrief: Motus GI Holdings Inc Continuing To Explore A Range Of Strategic And Financing Alternatives
Brief: Motus Gi Holdings Files Prospectus Related To Resale Of Up To 4.4 Million Shares Of Common Stock, By The Selling Stockholder
Brief: Motus GI Granted A U.S. Patent For Key Feature Embodied By The Pure-Vu System
U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Brief: Motus Gi Holdings Says Prices Public Offering At $1.50 Per Share